Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
May 14, 2024 16:05 ET
|
Serina Therapeutics, Inc.
HUNTSVILLE, May 14, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery...
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
March 26, 2024 17:04 ET
|
Serina Therapeutics
Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the...